Cargando…

Epilepsy Gene Therapy Using an Engineered Potassium Channel

Refractory focal epilepsy is a devastating disease for which there is frequently no effective treatment. Gene therapy represents a promising alternative, but treating epilepsy in this way involves irreversible changes to brain tissue, so vector design must be carefully optimized to guarantee safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Snowball, Albert, Chabrol, Elodie, Wykes, Robert C., Shekh-Ahmad, Tawfeeq, Cornford, Jonathan H., Lieb, Andreas, Hughes, Michael P., Massaro, Giulia, Rahim, Ahad A., Hashemi, Kevan S., Kullmann, Dimitri M., Walker, Matthew C., Schorge, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468110/ https://www.ncbi.nlm.nih.gov/pubmed/30755487 http://dx.doi.org/10.1523/JNEUROSCI.1143-18.2019

Ejemplares similares

Semiology, clustering, periodicity and natural history of seizures in an experimental occipital cortical epilepsy model
por: Chang, Bao-Luen, et al.
Publicado: (2018)

Biochemical autoregulatory gene therapy for focal epilepsy
por: Lieb, Andreas, et al.
Publicado: (2018)

In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy
por: Colasante, Gaia, et al.
Publicado: (2020)

Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy
por: Shekh-Ahmad, Tawfeeq, et al.
Publicado: (2019)

Designer receptor technology for the treatment of epilepsy
por: Lieb, Andreas, et al.
Publicado: (2019)

Drugs acting at TRPM7 channels inhibit seizure‐like activity
por: Khalil, Aytakin, et al.
Publicado: (2023)

Induction of the Nrf2 Pathway by Sulforaphane Is Neuroprotective in a Rat Temporal Lobe Epilepsy Model
por: Sandouka, Sereen, et al.
Publicado: (2021)

KCC2 overexpression prevents the paradoxical seizure-promoting action of somatic inhibition
por: Magloire, Vincent, et al.
Publicado: (2019)

Alternative Splicing Modulates Inactivation of Type 1 Voltage-gated Sodium Channels by Toggling an Amino Acid in the First S3-S4 Linker
por: Fletcher, Emily V., et al.
Publicado: (2011)

Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model
por: Khan, Archie A, et al.
Publicado: (2018)

Approaches for Reactive Oxygen Species and Oxidative Stress Quantification in Epilepsy
por: Olowe, Rhoda, et al.
Publicado: (2020)

Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias
por: Rajakulendran, Sanjeev, et al.
Publicado: (2010)

Specific inhibition of NADPH oxidase 2 modifies chronic epilepsy
por: Singh, Prince Kumar, et al.
Publicado: (2022)

On-demand cell-autonomous gene therapy for brain circuit disorders
por: Qiu, Yichen, et al.
Publicado: (2022)

Chemical–genetic attenuation of focal neocortical seizures
por: Kätzel, Dennis, et al.
Publicado: (2014)

Nrf2 is predominantly expressed in hippocampal neurons in a rat model of temporal lobe epilepsy
por: Sandouka, Sereen, et al.
Publicado: (2023)

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
por: Weston, Mikail, et al.
Publicado: (2019)

The Enlightened Brain: Novel Imaging Methods Focus on Epileptic Networks at Multiple Scales
por: Rossi, L. Federico, et al.
Publicado: (2018)

Long‐term potentiation in neurogliaform interneurons modulates excitation–inhibition balance in the temporoammonic pathway
por: Mercier, Marion S., et al.
Publicado: (2022)

Activity Clamp Provides Insights into Paradoxical Effects of the Anti-Seizure Drug Carbamazepine
por: Morris, Gareth, et al.
Publicado: (2017)

Erratum: K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy
por: D'Adamo, Maria C., et al.
Publicado: (2014)

Focal cortical seizures start as standing waves and propagate respecting homotopic connectivity
por: Rossi, L. Federico, et al.
Publicado: (2017)

On Bromide of Potassium in Epilepsy
por: Renton, J. Crawford
Publicado: (1878)

Bromide of Potassium in Epilepsy
Publicado: (1872)

Bromide of Potassium in Epilepsy
por: Evans, Horace Y.
Publicado: (1867)

Bromide of Potassium in Epilepsy
por: Hammond, William A.
Publicado: (1869)

K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy
por: D'Adamo, Maria Cristina, et al.
Publicado: (2013)

Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy
por: Sandouka, Sereen, et al.
Publicado: (2023)

Dendritic NMDA receptors in parvalbumin neurons enable strong and stable neuronal assemblies
por: Cornford, Jonathan H, et al.
Publicado: (2019)

Epilepsy Treated by Bromide of Potassium
Publicado: (1872)

Epilepsy and the Administration of Bromide of Potassium
por: Rogers, G. Goddard
Publicado: (1865)

Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
por: Turner, Thomas J., et al.
Publicado: (2020)

Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
por: Barrese, Vincenzo, et al.
Publicado: (2010)

Large Doses of the Bromide of Potassium in Epilepsy
por: Macfarlane, William
Publicado: (1874)

Epilepsy Successfully Treated by Bromide of Potassium
Publicado: (1865)

Deletion of the potassium channel Kv12.2 causes hippocampal hyperexcitability and epilepsy
por: Zhang, Xiaofei, et al.
Publicado: (2010)

The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands
por: Li, Ping, et al.
Publicado: (2013)

Glycine receptor autoantibodies disrupt inhibitory neurotransmission
por: Crisp, Sarah J, et al.
Publicado: (2019)

The Impact of Potassium Channel Gene Polymorphisms on Antiepileptic Drug Responsiveness in Arab Patients with Epilepsy
por: AL-Eitan, Laith N., et al.
Publicado: (2018)

Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
por: Zhang, Xinyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rpclfh2jpe2cmv8mdv8c8sa674